AlphaCrest Capital Management’s Karyopharm Therapeutics KPTI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,733	Closed	-$274K	–	1295
2021 Q1	$274K	Buy	1,733 +606	+54%	+$95.8K	0.02%	1040
2020 Q4	$262K	Sell	1,127 -220	-16%	-$51.1K	0.02%	967
2020 Q3	$295K	Buy	+1,347	New	+$295K	0.03%	866